Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility.

By A. Manca, N. Hawkins, M. Sculpher. Health Economics, 2005

967 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/d9cbef50c04835d6716284bdb845490bf1e65590

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Statistics and Probability

1. K. van Steen

Citations in the corpus

• Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease. (2015, methodology): “QALY were adjusted for differences in baseline utility scores (EuroQol-5D score) using a multiple regression approach.(20) Uncertainty in incremental QALY and costs was”
• Trial of early, goal-directed resuscitation for septic shock. (2015, neutral): “University College Hospital Teaching March 2011 - July 2014 665 129000 33 16 ED (8)/CCU (14)/Ward (1) 13 (81.”